EP3654976A1 — Methods of use of ultra-high dose rate radiation and therapeutic agents
Assigned to Varian Medical Systems Inc · Expires 2020-05-27 · 6y expired
What this patent protects
The present invention provides methods of treating tumors by administering FLASH radiation and a therapeutic agent to a cancer patient. The methods have the dual benefit of antitumor efficacy and normal tissue protection when combining therapeutic agents with FLASH radiation to t…
USPTO Abstract
The present invention provides methods of treating tumors by administering FLASH radiation and a therapeutic agent to a cancer patient. The methods have the dual benefit of antitumor efficacy and normal tissue protection when combining therapeutic agents with FLASH radiation to treat cancer patients. The methods of the present invention also allow classification of patients into groups to receive optimized radiation treatment in combination with an immunomodulator based on patient-specific biomarker signatures. Also provided are methods and systems for radiotherapy planning incorporating FLASH radiation and therapeutic agents.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.